Home / Health / New Covid Variant BA.3.2 Evades Vaccines
New Covid Variant BA.3.2 Evades Vaccines
24 Mar
Summary
- BA.3.2 variant identified with potential to evade vaccine protection.
- Variant shows significant genetic changes in spike protein.
- BA.3.2 has been detected in wastewater and travelers across the US.
A novel COVID-19 variant, BA.3.2, is circulating in the United States and raises concerns about its potential to evade protection from current vaccines. First detected in South Africa in 2024 and later in the U.S. in June 2025, BA.3.2 has seen a surge since September 2025 and has been reported in 23 countries.
The variant possesses approximately 70 to 75 genetic alterations in its spike protein, a key component for viral entry and immune evasion. Laboratory studies indicate that BA.3.2 can evade antibodies generated by existing COVID-19 vaccines, possibly necessitating an update to vaccine formulations. While not currently a dominant strain, its genetic distinctiveness warrants monitoring.
BA.3.2 has been identified in multiple U.S. states through traveler screenings and wastewater surveillance, suggesting a broader presence than initially observed. Despite detection in hospitalized patients, researchers caution that this does not necessarily indicate increased disease severity or specific risk factors. COVID-19 continues to evolve, highlighting the importance of ongoing surveillance and adaptive public health responses.
